Cargando…
HPV and cervical cancer: screening or vaccination?
Following the demonstration of the superior validity of human papillomavirus (HPV) tests in screening for cervical cancer and the arrival of highly efficacious HPV 16 and 18 vaccines, cervical cancer prevention enters a time of sustainable introduction in developing countries. Multidisciplinary effo...
Autores principales: | Bosch, F X, Castellsagué, X, de Sanjosé, S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359713/ https://www.ncbi.nlm.nih.gov/pubmed/18182975 http://dx.doi.org/10.1038/sj.bjc.6604146 |
Ejemplares similares
-
Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India
por: Diaz, M, et al.
Publicado: (2008) -
K.03 HPV vaccines: New opportunities for global cervical cancer prevention
por: Bosch, F.X.
Publicado: (2009) -
Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries
por: Louie, K S, et al.
Publicado: (2009) -
False positive cervical HPV screening test results
por: Schiffman, Mark, et al.
Publicado: (2019) -
Estimation of the epidemiological burden of HPV-related anogenital cancers, precancerous lesions, and genital warts in women and men in Europe: Potential additional benefit of a nine-valent second generation HPV vaccine compared to first generation HPV vaccines
por: Hartwig, Susanne, et al.
Publicado: (2015)